Sylebra Capital LLC, an entity classified as a director for reporting purposes, executed a series of stock sales totaling approximately $7.41 million in Impinj Inc. (NASDAQ: PI) during early June 2026. The transactions occurred as the stock experienced a notable short-term decline. Despite the insider selling, the company recently reported strong first-quarter financial results that surpassed analyst expectations, and UBS has upgraded its price target, indicating underlying operational progress.
The sale involved a total of 57,633 shares of the company’s common stock. The transactions were executed over June 8 and June 9, 2026, with prices ranging from $125.9651 to $130.0685 per share. This divestment occurs against a backdrop of recent market pressure, as Impinj shares have declined 9.2% over the past week, trading at $122.69. According to InvestingPro analysis, the stock appears overvalued at current levels based on Fair Value estimates. The platform offers 15 additional ProTips for PI investors seeking deeper insights.
On June 8, Sylebra Capital sold 12,528 shares and an additional 33,000 shares. On June 9, another 12,105 shares were sold. Following these sales, Sylebra Capital LLC indirectly holds 782,943 shares of Impinj common stock. The shares are held indirectly by Sylebra Capital LLC through Sylebra Capital Partners Master Fund, Ltd., Sylebra Capital Menlo Master Fund, and other advisory clients. Daniel Patrick Gibson, a founder and Chief Investment Officer of Sylebra Capital Management, is also a member of Impinj’s board of directors. Sylebra Capital LLC, Sylebra Capital Limited, Sylebra Capital Management, and Mr. Gibson disclaim beneficial ownership of these securities, except to the extent of their pecuniary interest. The transactions were reported in a Form 4 filing with the Securities and Exchange Commission on June 10, 2026.
In other recent news, Impinj Inc. reported impressive financial results for the first quarter of 2026. The company exceeded earnings expectations with an earnings per share (EPS) of $0.14, surpassing the anticipated $0.11 by 27.27%. Additionally, Impinj’s revenue reached $74.3 million, outperforming the forecasted $72.59 million. These results highlight the company’s strong performance and have bolstered investor confidence. In related developments, UBS has raised its price target for Impinj to $175 from $155, maintaining a Neutral rating on the stock. The firm expressed optimism regarding Impinj’s progress in managing channel inventories, which are now largely cleared. UBS noted improvements in demand drivers, particularly in retail recovery and the UPS program’s shift toward ASICs. These recent developments reflect positive momentum for Impinj as it navigates the current market landscape.
Market data indicates Impinj closed at 122.69, reflecting a decline of 2.35 (1.88%). After hours trading showed a neutral movement of 0.00 (0.00%). The stock is included in AI-picked strategies, with tools available to review strategies. The data point 122.69 is highlighted, showing the current valuation context for investors analyzing the ticker.